“…Pharmacological experiments also revealed some distinctive features of P2X4 receptors: ivermectin (IVM) was an allosteric modulator of P2X4 receptors (Khakh et al, 1999b;Priel and Silberberg, 2004), they were relatively resistant to P2X antagonists (Buell et al, 1996;Jones et al, 2000), and antidepressants reduced P2X4 responses (Nagata et al, 2009). Additionally, P2X4 receptors form functional heteromers with P2X6 subunits (Lê et al, 1998a;Ormond et al, 2006) and undergo interactions with P2X7 receptors (Guo et al, 2007;Nicke, 2008;Alqallaf et al, 2009;Boumechache et al, 2009;Casas-Pruneda et al, 2009;MurrellLagnado, 2009). Progress has also been made in understanding the cell biology of P2X4 receptors, with evidence to suggest that they undergo endocytosis and traffic to lysosomes Royle et al, 2002;Toulmé et al, 2006;Qureshi et al, 2007;Stokes and Surprenant, 2009).…”